| Vial description: |
ADA2, IDGFL |
| Category: |
antigen |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
Purified |
| Reactivity: |
not determined |
| Purity: |
>, 90% |
| Molecular weight: |
56, 9 kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
Q9NZK5 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Conjugation: |
histidine |
| Gene target: |
His-tag), CECR1 (30-511 |
| Short name: |
His-tag) Antibody, anti-CECR1 (30-511 |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Label: |
His |
| Alternative name: |
candidate 1 (30-511, histidine-detection labelled) (Antibody to), antibody to-catalase eye syndrome chromosome region |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CECR1 and IDBG-641275 and ENSBTAG00000017313 and 617805, CECR1 and IDBG-933 and ENSG00000093072 and 51816, Extracellular, candidate 1, proteoglycan binding, this GO :0004000 and adenosine deaminase activity and molecular function this GO :0005615 and extracellular space and cellular component this GO :0006154 and adenosine catabolic process and biological process this GO :0007275 and multicellular organismal development and biological process this GO :0008083 and growth factor activity and molecular function this GO :0008152 and metabolic process and biological process this GO :0008201 and heparin binding and molecular function this GO :0008270 and zinc ion binding and molecular function this GO :0019239 and deaminase activity and molecular function this GO :0031685 and adenosine receptor binding and molecular function this GO :0042803 and protein homodimerization activity and molecular function this GO :0043103 and hypoxanthine salvage and biological process this GO :0043394 and proteoglycan binding and molecular function this GO :0046103 and inosine biosynthetic process and biological process, this GO :0004000 : adenosine deaminase activity, this GO :0004000 : adenosine deaminase activity and also this GO :0008083 : growth factor activity and also this GO :0008201 : heparin binding and also this GO :0008270 : zinc ion binding and also this GO :0019239 : deaminase activity and also this GO :0031685 : adenosine receptor binding and also this GO :0042803 : protein homodimerization activity and also this GO :0043394 : proteoglycan binding, this GO :0008083 : growth factor activity, this GO :0008201 : heparin binding, this GO :0008270 : zinc ion binding, this GO :0019239 : deaminase activity, this GO :0031685 : adenosine receptor binding, this GO :0042803 : protein homodimerization activity, this GO :0043394 : proteoglycan binding, cat eye syndrome chromosome region |
| Identity: |
1839 |
| Gene: |
ADA2 |
More about : ADA2 |
| Long gene name: |
adenosine deaminase 2 |
| Synonyms gene: |
IDGFL CECR1 |
| Synonyms gene name: |
candidate 1 , cat eye syndrome chromosome region |
| Synonyms: |
ADGF |
| Locus: |
22q11, 1 |
| Discovery year: |
1999-12-09 |
| GenBank acession: |
AF190746 |
| Entrez gene record: |
51816 |
| Pubmed identfication: |
10756095 27663683 |
| Classification: |
Adenosine deaminase family |
| Havana BLAST/BLAT: |
OTTHUMG00000030726 |